Hongbo Lu
Director · Zenas BioPharma, Inc.
- 2024
- Jun 17, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Hongbo Lu files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christopher Richard Anzalone - $12.35M in ARWR purchases and sales in the last 12 months
- Leon O. Moulder Jr. - $4.12M in ZBIO purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $3.00M in ZBIO purchases and sales in the last 12 months
- James C. Hamilton - $1.39M in ARWR purchases and sales in the last 12 months
- Michael S. Perry - $1.01M in ARWR purchases and sales in the last 12 months
- Daniel Joseph Apel - $934K in ARWR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Hongbo Lu?
Hongbo Lu is a corporate insider, tracked as Director of Zenas BioPharma, Inc. (ZBIO). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Hongbo Lu last file a Form 4?
The most recent primary Form 4 on record is dated 17 June 2026, one of 7 filings going back to 2024.
Has Hongbo Lu been buying or selling stock?
Recorded transactions: 5 open-market purchases ($8.15M) and 1 open-market sale ($228K) across all tracked filings.
